WOMEN S HEALTH

Reuters reported on 21 October that researchers studying more than 2,000 pregnant women identified antibodies against IL-1RA, a protein that normally restrains inflammation, in some pregnancies that ended before 37 weeks. Experiments in mice showed that these antibodies could trigger inflammation and placental damage.

Reuters reported on 21 October that researchers identified antibodies that neutralise IL-1RA, a protein that normally helps restrain inflammation, in some pregnancies that ended before 37 weeks. Experiments in mice showed increased inflammation and placental damage after exposure to these antibodies.

Reuters and the Associated Press reported on 19 October that the United States announced a new Women's Health Division within the National Institutes of Health and a White House Women's Health Task Force. The initiative aims to improve research, diagnosis and treatment for conditions that uniquely or disproportionately affect women.

University College London reported on 13 October that a review of 12 randomised controlled trials involving more than 1,000 women found that physical activity may improve psychological wellbeing and quality of life during perimenopause and early post-menopause.

Research reported by Medical Xpress on 16 October found that treating depression during pregnancy may influence infant brain development and early emotional functioning. The findings highlight the importance of addressing maternal mental health during pregnancy.

Research reported by Reuters on 16 October found that ovaries may continue to undergo biological changes for decades after menopause, including changes in tissue structure and inflammation-related proteins. The findings may help researchers investigate ovarian ageing and its relationship with disease.

Research reported on 16 October 2026 identified gaps in endometriosis guidelines worldwide, including limited representation of adolescents, gender-diverse people, and individuals with lived experience of the condition. The findings suggest that clinical guidance may not consistently address the needs of all patients. Greater international coordination could help improve recognition, diagnosis, treatment decisions, and long-term support.

Researchers at Cold Spring Harbor Laboratory reported a potential link between certain autoantibodies and preterm birth. The study, reported on 13 October 2026 by the University of California, San Francisco, explores whether immune responses during pregnancy could help explain why some women enter labour too early. The findings may provide a direction for future research into identifying high-risk pregnancies, but they do not establish a routine screening test or a proven method for preventing preterm birth.

A study reported on 13 October 2026 found that extending Medicaid coverage to 12 months after childbirth increased postpartum healthcare utilization among women who had experienced high-risk pregnancy complications, including diabetes and hypertension. The findings emphasize that medical care after delivery can be important for identifying persistent health problems and managing conditions that may increase long-term cardiovascular and metabolic risks. Penn Medicine

Preliminary research suggests that women with bipolar disorder who have regular menstrual cycles may be more likely to report severe premenstrual symptoms than women with irregular cycles. The findings raise questions about whether menstrual patterns influence the recognition and management of symptoms.

A new women's-health report examines secondary infertility, a condition in which a person has difficulty conceiving or carrying another pregnancy after previously having a child. Potential factors include age-related changes, ovulation problems and reproductive health conditions.

The FDA has announced that its safety review of mifepristone will continue into 2027, with a safety study expected to be completed later this year and findings planned for publication in 2027.